Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3182
Selected: 0
NCT IDTitle
NCT00465179Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
NCT05349227Comprehensive Outcomes for After Cancer Health
NCT02525757MPDL3280A With Chemoradiation for Lung Cancer
NCT00794820Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
NCT02807883Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia
NCT02520154Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02532257Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma
NCT04991870Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
NCT00508456Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
NCT01024166Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study
NCT05010122ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NCT01531361Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations
NCT01895842Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
NCT04739072Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
NCT06584955Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients With Hematological Malignancies
NCT06550050Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
NCT02661282Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
NCT01924169Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
NCT00976898Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
NCT057559843D Printed Breast Models in the Surgical Management of Breast Cancer
NCT00047710Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer
NCT06435286Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
NCT03168763Effect of Physician Attire on Patients' Preference of Physician
NCT03892993Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
NCT02456857Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
NCT06616636A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
NCT00418899Gliogene: Brain Tumor Linkage Study
NCT03290937Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer
NCT00378781Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
NCT04491292Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
NCT00941499Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab
NCT05038098Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
NCT01606293Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix
NCT00664404Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal
NCT06535828AIM4 AI and Mechanistic Modeling in Molecular Medicine
NCT04098744Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
NCT04693364Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment
NCT00354887Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
NCT05035732A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)
NCT00499421Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
NCT04594187Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
NCT00411593Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)
NCT04965714Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer
NCT00507247Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
NCT01718743Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT06446713PIRATES: Image-guided Hyper-fractioned Dose-escalation With Proton Therapy for Head and Neck Cancer
NCT05497024Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
NCT04106843Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers
NCT04771806Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
NCT02096055Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia